Industry Outlook, Reliance on Global State - Equity Research on Regeneron Pharmaceuticals, Inc. and Amgen, Inc.
(firmenpresse) - HONG KONG -- (Marketwire) -- 09/07/11 -- Today, released its industry report highlighting Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Amgen, Inc. (NASDAQ: AMGN). Full fundamental and technical analysis is available at .
Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.
As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.
World Street Fundamentals has highlighted Regeneron Pharmaceuticals, Inc. as a biopharmaceutical company. Regeneron discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The entire report on Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is available here: .
World Street has featured Amgen, Inc. as an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. The entire report on Amgen, Inc. (NASDAQ: AMGN) is available here: .
About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.
Contact:
Adam Redford
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.09.2011 - 13:00 Uhr
Sprache: Deutsch
News-ID 62975
Anzahl Zeichen: 0
contact information:
Town:
HONG KONG
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 169 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Industry Outlook, Reliance on Global State - Equity Research on Regeneron Pharmaceuticals, Inc. and Amgen, Inc."
steht unter der journalistisch-redaktionellen Verantwortung von
World Street Fundamentals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
